-+ 0.00%
-+ 0.00%
-+ 0.00%

PMV Pharma FY 2024 GAAP EPS $(1.14) Misses $(1.08) Estimate

Benzinga·03/03/2025 13:07:10
Listen to the news

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.08) by 5.56 percent.